Canopy Growth (CGC:TSXV) stabilized Monday, rising 2.2% on 1.8 million shares traded, after selling off to finish last week.


Canopy and OrganiGram move to secure cash


A few companies, including Canopy Growth and OrganiGram, moved swiftly to capitalize on the recent spike in interest related to the marijuana sector.

On October 23rd, Canopy Growth announced a $12.5 million bought deal. The price? $2.05 per share. Now, this seemed like a good price to many, especially considering Canopy Growth closed at $1.58 on October 2nd. However, what the company probably didn’t bank on was that its shares would hit a high of $3.69 on November 5th. Now, with a $2.05 private placement agreed upon, but not yet closed, Canopy Growth is giving back some of its gains. After two days of selling pressure and declines, Canopy rebounded 2.2% to close at $2.71 per share Monday afternoon.


Canopy Growth – 3 Month Chart



In respect to the financing, the company reported:

“The closing date of the Offering is scheduled to be on or about November 17, 2015 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities.”

Click here to read the entire press release.


Tweed was among the first companies to receive a licensed under the Marihuana for Medical Purposes Regulations to produce and sell marijuana to authorized customers.

Canopy Growth’s Tweed goes Jamaican


Canopy Growth‘s wholly-owned subsidiary Tweed announced in October that it will sponsor the High Times 2015 Jamaican & World Cannabis Cups taking place in Negril, Jamaica.

Blaine Dowdle, Tweed’s Head of International Development, commented that:

“Today marks a significant step forward for Tweed as we prepare to move outside our Canadian borders and begin building relationships with the Rastafari community in Jamaica.”

Tweed reported that:

“The Jamaican market is a logical place for Tweed to extend its brand presence outside of Canada. In addition to recently relaxed cannabis laws, the island of Jamaica and the Jamaican people have a long and established history with the cannabis plant.”

Click here to read the entire press release.

OrganiGram moves to capitalize on rising stock


OrganiGram reported on November 5th that it “will issue an aggregate of 3,298,077 units (“Units”) at a price of $1.04 per Unit (the “Offering Price”) for net proceeds of $3,430,000.”

Click here to read all the details about OrganiGram’s latest financing.


What is so amazing about this announcement is that less than a month earlier, OrganiGram traded for just $0.195 per share. It has been a while since the TSX Venture provided these types of gains in any one sector.
In our latest EBook we reveal 50 leaders who took small-cap stocks to stunning multimillion, and in some cases billion, dollar buyouts. The companies these leaders run today are also described in this one of a kind rolodex of some of the top entrepreneurs and business minds operating in North America’s small cap public markets.

Click the below image to get your free copy today. new-ebook_56

Three of the TSX Venture’s 10 most liquid stocks on Monday were from the marijuana sector. We’ve written about increasing interest in the marijuana space for weeks at Pinnacle and summed up the opportunity in a Weekly Volume titled Trudeau bets $1 billion on this sector.

The Venture gave up ground Monday, falling half a point as all North American indices declined in value. Canopy Growth and OrganiGram are expecting the newly elected Liberal government to legalize recreational marijuana in the near future.



This article represents solely the opinions of Alexander Smith. Alexander Smith is not an investment advisor and any reference to specific securities in the list referred to in the article does not constitute a recommendation thereof. Readers are encouraged to consult their investment advisors prior to making any investment decisions. The information in this article is of an impersonal nature and should not be construed as individualized advice or investment recommendations.

This is not an invitation to purchase any securities mentioned in this report. Pinnacle Digest does not endorse or recommend any of the referenced securities. At the time of publication and distribution of this report (3:15PM PST on November 9, 2015) neither, its employees or consultants owned shares in any of the mentioned companies in this report. This article is intended for informational and entertainment purposes only. The author of this article bears no liability for losses and/or damages arising from the use of this article. This report may contain technical or other inaccuracies, omissions, or typographical errors, for which and its parent company assumes no responsibility. We do not guarantee that any of the companies mentioned in this report or on will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

All statements in this report, other than statements of historical fact, should be considered forward-looking statements. These statements relate to future events or future performance. Much of this report is comprised of statements of projection. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. and its employees are not a registered broker-dealer or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer. Nothing in this article should be construed as a solicitation to buy or sell any securities. This article is intended for informational and entertainment purposes only. The author of this article bears no liability for losses and/or damages arising from the use of this article.